FDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Mar 20
Select Taste of Inspirations Wing Sauce Lots Recalled Due to Undeclared Allergen
Food & Beverages
Mar 20
Food Lion Recalls Select Taste of Inspirations Parmesan Garlic Wing Sauce
Food & Beverages
Mar 19
Three Turkey Wrap Sandwiches Added to Mg Foods’ Previous Recall List Due to Possible Listeria Monocytogenes Contamination
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA’s Ongoing Use of Inspectional Tools for Ensuring Access to Safe, Quality Food and Medical Products During the COVID-19 Pandemic
Over the past year, FDA’s approach to foreign and domestic inspections for food and medical products has been both risk-based and deliberate.
FDA’s Partnership with Mexico’s Regulators Strengthens Food Safety Protections
The FDA-Mexico Food Safety Partnership broadens and strengthens the scope of our existing partnership to include the safety of all human food regulated by FDA.
Leveraging Real World Evidence in Regulatory Submissions of Medical Devices
FDA makes available examples of Real-World Evidence (RWE) used in medical device regulatory decisions.
Recently Published Guidances
Mar 04
COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers Guidance for Industry
Biologics, Drugs
Feb 22
Development of Monoclonal Antibody Products Targeting SARS-CoV-2, Including Addressing the Impact of Emerging Variants, During the COVID 19 Public Health Emergency
Drugs
Feb 22
Emergency Use Authorization for Vaccines to Prevent COVID-19
Biologics